A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Onychomycosis
Interventions
DRUG

MOB015B

Applied topically for 48 weeks

DRUG

Vehicle (Placebo Comparator)

Applied topically for 48 weeks

Trial Locations (35)

10021

Weill Cornell Medicine Dermatology, New York

11415

Forest Hills Dermatology Group, Kew Gardens

14623

Skin Search of Rochester, Rochester

15213

UPMC Department of Dermatology, Pittsburgh

17402

Martin Foot and Ankle, York

23502

Virginia Clinical Research, Inc., Norfolk

27516

UNC Dermatology and Skin Cancer Center, Chapel Hill

29405

Coastal Carolina Research Center, North Charleston

33134

Driven Research LLC, Coral Gables

33143

Doctors Research Institute Corporation, South Miami

33756

Olympian Clinical Research, Clearwater

35233

University of Alabama Hospital, Birmingham

37215

Tennessee Clinical Research Center, Nashville

44122

Haber Dermatology, Inc., Beachwood

46617

The South Bend Clinic, LLC, South Bend

48038

Michigan Center for Skin Care Research, Clinton Township

48103

David Fivenson, MD, Dermatology, PLLC, Ann Arbor

55112

Associated Skin Care Specs, New Brighton

62269

Podiatry 1st, O'Fallon

68144

Skin Specialists, PC, Omaha

70809

DelRicht Research - Baton Rouge, Baton Rouge

71201

IMA Clinical Research, Monroe

77479

Houston Center for Clinical Research, Sugar Land

78213

Progressive Clinical Research, PA, San Antonio

78501

Futuro Clinical Trials LLC, McAllen

78759

DermResearch, Inc., Austin

80210

Colorado Medical Research Center, Denver

90045

Dermatology Research Associates, Los Angeles

92024

California Dermatology & Clinical Research Institute, Encinitas

94115

Center for Clinical Research, San Francisco

94538

Center for Dermatology Clinical Research,Inc, Fremont

97210

Oregon Dermatology and Research Center, Portland

08009

Hassman Research Institute, Berlin

N5X 2P1

Mediprobe Research, London

Unknown

Toronto Research Centre, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Moberg Pharma AB

INDUSTRY